MRM Proteomics Inc. is a Canadian biotechnology company based in Montréal, Québec, with a subsidiary in Russelsheim, Germany, specializing in targeted proteomics and absolute quantitation of proteins using mass spectrometry. The company develops and commercializes advanced proteomics solutions, including assays, kits, standards, and analytical services, with a strong focus on clinical and translational research.
MRM Proteomics leverages state-of-the-art mass spectrometry technologies and proprietary workflows to deliver high-quality, reproducible, and cost-effective quantitative data. The company is transitioning from a service-oriented model to a product-driven strategy, with flagship products designed to democratize access to absolute quantitative proteomics for academic, clinical, and industrial users.
With expertise spanning assay development, isotopically labelled standards, and biomarker validation, MRM Proteomics collaborates closely with academic institutions, clinical laboratories, and industry partners to accelerate innovation and market adoption.